Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Información selecta para pacientes y cuidadores que se encuentra disponible en Español.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

AZULFIDINE®Principal Display Panel (sulfasalazine)

PRINCIPAL DISPLAY PANEL - 500 mg Tablet Bottle Label

NDC 0013-0101-01
Rx Only

Pfizer

Azulfidine®

sulfasalazine
tablets, USP

500 mg

100 Tablets

PRINCIPAL DISPLAY PANEL - 500 mg Tablet Bottle Label

PRINCIPAL DISPLAY PANEL - 500 mg Tablet Bottle Label - 0101-10

Pfizer
NDC 0013-0101-10
Rx Only

Azulfidine®

sulfasalazine
tablets, USP

500 mg

100 Tablets

PRINCIPAL DISPLAY PANEL - 500 mg Tablet Bottle Label - 0101-10

PRINCIPAL DISPLAY PANEL - 500 mg Tablet Bottle Carton - 0101-10

Pfizer
NDC 0013-0101-10

Azulfidine®

sulfasalazine
tablets, USP

500 mg

Rx only

100 Tablets

PRINCIPAL DISPLAY PANEL - 500 mg Tablet Bottle Carton - 0101-10
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event